About
Cancer Treatments
Areas of Focus
Categories
Small Molecule PharmaceuticalVirginia, DC, DE & Maryland
Team (16)
Aimee Crombie
Aimee Crombie, Ph.D.
Prelude Therapeutics
team_member
Andrew Combs
Andrew Combs, Ph.D.
Prelude Therapeutics
team_member
Bryant Lim
Bryant Lim
Prelude Therapeutics
team_member
David Bonita
David Bonita, M.D.
Prelude Therapeutics
team_member
Jane Huang
Jane Huang, M.D.
Prelude Therapeutics
team_member
Katina Dorton
Katina Dorton, J.D., M.B.A.
Prelude Therapeutics
team_member
Clinical Trials (11)
View allTotal Trials
11
As Lead Sponsor
11
As Collaborator
0
Total Enrollment
765
By Phase
PHASE2: 1PHASE1: 10
By Status
COMPLETED: 7ACTIVE_NOT_RECRUITING: 2RECRUITING: 1TERMINATED: 1
Clinical Trials Pipeline11 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06682806Lead Sponsor
A Study of PRT3789 in Combination With Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation
PHASE2Active, not recruiting
7 participants
Started: Jun 3, 2025 · Completed: Dec 31, 2027
NCT06560645Lead Sponsor
A Study of PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation
PHASE1Recruiting
104 participants
Started: Nov 4, 2024 · Completed: Apr 30, 2027
NCT05665530Lead Sponsor
A Study of PRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With R/R Hematologic Malignancies
PHASE1Active, not recruiting
86 participants
Started: Sep 12, 2023 · Completed: Mar 31, 2026
NCT05639751Lead Sponsor
PRT3789 Monotherapy and in Combo w/Docetaxel in Participants w/Advanced or Metastatic Solid Tumors w/SMARCA4 Mutation
PHASE1Completed
135 participants
Started: May 2, 2023 · Completed: Oct 1, 2025
NCT05538572Lead Sponsor
A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors
PHASE1Completed
22 participants
Started: Dec 27, 2022 · Completed: Jun 26, 2024
Locations (1)
Headquarters
Wilmington, DE, United States
Map
Loading map...